跳转至内容
Merck
CN
  • Notch1-STAT3-ETBR signaling axis controls reactive astrocyte proliferation after brain injury.

Notch1-STAT3-ETBR signaling axis controls reactive astrocyte proliferation after brain injury.

Proceedings of the National Academy of Sciences of the United States of America (2015-07-01)
Matthew D LeComte, Issei S Shimada, Casey Sherwin, Jeffrey L Spees
摘要

Defining the signaling network that controls reactive astrogliosis may provide novel treatment targets for patients with diverse CNS injuries and pathologies. We report that the radial glial cell antigen RC2 identifies the majority of proliferating glial fibrillary acidic protein-positive (GFAP(+)) reactive astrocytes after stroke. These cells highly expressed endothelin receptor type B (ETB(R)) and Jagged1, a Notch1 receptor ligand. To study signaling in adult reactive astrocytes, we developed a model based on reactive astrocyte-derived neural stem cells isolated from GFAP-CreER-Notch1 conditional knockout (cKO) mice. By loss- and gain-of-function studies and promoter activity assays, we found that Jagged1/Notch1 signaling increased ETB(R) expression indirectly by raising the level of phosphorylated signal transducer and activator of transcription 3 (STAT3), a previously unidentified EDNRB transcriptional activator. Similar to inducible transgenic GFAP-CreER-Notch1-cKO mice, GFAP-CreER-ETB(R)-cKO mice exhibited a defect in reactive astrocyte proliferation after cerebral ischemia. Our results indicate that the Notch1-STAT3-ETB(R) axis connects a signaling network that promotes reactive astrocyte proliferation after brain injury.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
泰莫西芬, ≥99%
Sigma-Aldrich
胶质纤维酸性蛋白(GFAP)单克隆抗体 小鼠抗, clone G-A-5, ascites fluid
Sigma-Aldrich
Anti-GAPDH,克隆6C5, clone 6C5, Chemicon®, from mouse
Sigma-Aldrich
抗-GAPDH 兔抗, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
γ分泌酶抑制剂 XX, This γ-secretase inhibitor, CAS 209984-56-5, is a cell-permeable dibenzazepine compound that lowers both brain and plasma Aβ40 levels by ~72% in Tg2576 mutant APP transgenic mouse model.